The CMS 2026 Medicare Physician Fee Schedule Final Rule delivers a 3.26% increase in payment rates for all physicians, offering temporary relief after years of declining real reimbursement. However, the increase comes with significant policy changes that practices must navigate carefully.
CMS finalized regulations requiring Medicaid coverage of anti-obesity medications when used to reduce excess body weight and maintain weight reduction long-term. These medications can no longer be excluded from Medicaid coverage and must be treated as covered outpatient drugs.
The proposed rule includes policies to remove unnecessary barriers to care by clarifying requirements for plan use of internal coverage criteria and proposing guardrails for the use of artificial intelligence to protect access to health services. CMS is addressing concerns that payers are using AI to inappropriately deny prior authorization requests.
The rate increase provides short-term financial relief, but practices should prepare for increased scrutiny of E/M coding following CMS's identification of $664 million in overpayments. Documentation supporting level 4 and 5 office visits must be airtight.
AHIP, BCBSA, and leading health plans representing nearly 270 million Americans announced multi-year voluntary commitments to streamline and simplify prior authorization, with major reforms taking effect January 1, 2026.
Faster Turnaround Times:
Beginning in 2026, impacted payers are required to send prior authorization decisions within 72 hours for expedited requests and 7 calendar days for standard requests for medical items and services.
90-Day Transition Period:
When a patient changes insurance companies during a course of treatment, the new plan will honor existing prior authorizations for benefit-equivalent in-network services as part of a 90-day transition period.
Transparency Requirements:
Health plans will provide clear, easy-to-understand explanations of prior authorization determinations, including support for appeals and guidance on next steps. In 2026, payers are required to publicly report prior authorization performance metrics.
In 2027, at least 80% of electronic prior authorization approvals (with all needed clinical documentation) will be answered in real-time, with adoption of FHIR APIs across all markets.
The WISeR (Wasteful and Inappropriate Services Reduction) pilot will require prior authorization for 17 procedures in six pilot states: Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington.
Providers not equipped for electronic prior authorization risk denials for "non-compliant submissions" as payers transition to API-based workflows. Implement electronic PA workflows now to comply with new payer response time requirements.
Artificial intelligence has moved from experimental pilot to operational standard in revenue cycle management. 63% of providers have already introduced AI in some capacity to their RCM workflows, with over 75% of U.S. health systems planning to expand AI-driven RCM automation by 2026.
While 63% of providers have introduced AI, only 15% have fully integrated AI into standard RCM operations. The gap between initial adoption and full integration reflects the complexity of revenue cycle workflows and the need for change management.
Top AI Use Cases in RCM:
In 2026, healthcare organizations are signaling a shift from experimentation to embedded strategy, moving from point solutions to platform approaches that integrate AI across the entire revenue cycle.
The biggest shift is the emergence of agentic AI — autonomous systems that stitch together all aspects of check-in, eligibility verification, coding, and denial management with minimal human intervention.
Organizations that have fully deployed AI across RCM report:
AI in RCM is no longer a competitive advantage — it's becoming table stakes. The question is no longer "should we adopt AI?" but "how fast can we scale it?"
The American Medical Association's CPT 2026 code set represents a historic milestone: for the first time, artificial intelligence is explicitly recognized in medical coding, with new codes describing services augmented by AI tools in addition to services performed by clinicians alone.
1. AI-Augmented Services
New codes describe clinician-directed artificial intelligence and assistive analytics, recognizing AI as a formal component of clinical workflow rather than a background support tool.
2. Digital Health Recognition
Expanded recognition of shorter-duration remote monitoring services, reflecting the evolution of remote patient monitoring beyond chronic disease management.
3. Hearing Device Services
New codes for hearing device services address gaps in coverage and documentation for audiology practices.
4. Lower-Extremity Revascularization
Comprehensive rebuild of lower-extremity revascularization codes to reflect modern interventional techniques and imaging integration.
The introduction of AI-augmented service codes signals the AMA's recognition that AI is now a standard tool in clinical care delivery, not an experimental technology. This creates both opportunities and documentation requirements:
Opportunities:
Documentation Requirements:
The CPT 2026 recognition of AI-augmented codes is the first formal step toward differential payment for AI-assisted care. Practices using AI tools should ensure documentation clearly describes the clinician's role in reviewing and validating AI outputs.
Denial rates have surged to nearly 15% across the industry, up from the historical average of 11.65%. This increase reflects intensified payer scrutiny, AI-powered denial engines, and the financial pressure on Medicare Advantage plans.
Out of the $3 trillion in total claims submitted by healthcare organizations yearly, roughly $262 billion are denied — translating to an average of nearly $5 million in denials per provider annually.
Additional denial statistics:
Payers are deploying AI to drive denials higher, while providers are fighting back with AI-powered denial prevention platforms. The result is an AI arms race in RCM.
Payer AI Tools:
Provider Defense:
The focus is moving upstream, with AI-driven denial prevention replacing traditional downstream appeals:
Old Model (Reactive):
Submit claim → Receive denial → Research → Appeal → Wait
New Model (Preventive):
Pre-submission AI scoring → Automated scrubbing → Payer-specific validation → Clean submission
Practices implementing AI-powered denial prevention report:
Payers under financial pressure will intensify downcoding, prior authorization requirements, and documentation scrutiny in 2026. Analysis shows denial activity increasingly occurs outside traditional remittance reporting and extends months beyond payment.
Days in Accounts Receivable (A/R) is the key metric for revenue velocity — the speed at which services rendered convert to cash collected. In 2026, the benchmark remains 30 days or less, but many practices are struggling to meet this target as payer policies tighten and payment delays extend to 45–90 days.
| Performance Level | Days in A/R | Assessment |
|---|---|---|
| Gold Standard | ≤ 30 days | Optimal revenue velocity |
| Acceptable | 30–40 days | High-performing practices |
| Warning Zone | 40–50 days | Indicates inefficiencies |
| Critical | > 50 days | Signals inefficient follow-up or payer delays |
As payer policies become more complex and Medicare regulations tighten, many practices are experiencing payment delays of 45–90 days, crippling cash flow and stalling growth. Internal medicine practices are struggling with skyrocketing A/R days, particularly in high-demand states such as California, Texas, and New York.
1. Fix Front-End Eligibility Verification
A mid-size clinic cut A/R by 12 days after fixing eligibility edits. Real-time eligibility verification prevents downstream denials and payment delays.
2. Automate Payment Posting
Manual payment posting creates 3–5 day delays. Automated posting with ERA (Electronic Remittance Advice) integration reduces A/R by 4–6 days.
3. Implement Daily Statement Cycles
Switching from monthly to daily statement cycles for patient balances accelerates collections by 10–15 days.
4. Deploy AI-Powered A/R Follow-Up
AI tools prioritize follow-up tasks based on dollar value, payer, and age, ensuring high-value claims receive immediate attention.
5. Track Payer Performance
Monitor Days in A/R by payer. Payers consistently exceeding 45 days should be escalated to provider relations for contract review.
Revenue velocity is the new battleground in RCM optimization. Practices that drive Days in A/R below 30 days gain significant cash flow advantages and can invest in growth while competitors struggle with working capital constraints.
On March 2, 2026, Procode AI emerged from stealth mode with $4 million in funding and the acquisition of The Auctus Group, an RCM company serving over 300 plastic surgery and dermatology providers.
Founded by tech entrepreneur Jeff Cripe, surgeon Kameron Rezzadeh, and engineer James Baez-Silva, Procode AI is pursuing an "acquire and enhance" strategy: acquiring existing RCM firms and providing tools that make them three to five times more effective and productive.
Core Product: Coding Copilot
Procode AI's flagship tool enables medical coders to code 90% faster and with greater accuracy by automatically translating operative reports into precise billing and diagnostic codes.
The acquisition signals a new consolidation wave in the RCM vendor market: AI-first companies acquiring traditional RCM providers and retrofitting them with autonomous coding and denial prevention tools.
Procode AI's focus on specialty-specific RCM (starting with plastic surgery and dermatology) reflects the market's shift from one-size-fits-all RCM platforms to specialty-optimized solutions.
The 2026 Best in KLAS Awards revealed significant performance gaps among RCM vendors:
| Category | Winner | Performance Score |
|---|---|---|
| Ambulatory RCM Services (EHR Agnostic) | Omega Healthcare | 92.2 / 100 |
| Extended Business Office: Small (<200 beds) | R1 RCM | Best in KLAS |
| Government Reimbursement Services | R1 RCM | Best in KLAS |
| Underpayment Recovery Services | R1 RCM | Best in KLAS |
Most Improved Vendor:
Greenway Health posted a 24% increase in satisfaction among its RCM clients, proving that legacy vendors can reinvent their culture and execution.
The RCM market is entering a consolidation phase driven by AI capabilities. Traditional RCM vendors must invest in AI platforms or risk being acquired by AI-first competitors.